INTERVIEW: Evelo’s SINTAX medicines could address a broad range of inflammatory disorders

Credit:DavidBGray on iStock Evelo Biosciences (Nasdaq:EVLO) is a clinical-stage biotechnology company that is focused on a newly uncovered area of central human

Addex Therapeutics CEO Tim Dyer: There is a $4-bil market opportunity in dyskinesia

Credit:DavidBGray on iStock Tell us a bit about your clinical programs and how they are different from the existing therapies. Addex is

Gett CEO Dave Waiser: We currently serve over 25% of Fortune 500 firms

What is Gett?  I founded the company in 2010 and we started in Israel as a ride-hailing company. Very quickly, we became

Earnings Calls

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

Microsoft (MSFT) becomes a compelling buy after strong earnings, Activision deal

Microsoft Corp. (NASDAQ: MSFT) is one of the most innovative technology companies, constantly transforming the business to align with the rapidly changing digital economy. While aggressively participating in the digital

January 26, 2022

Microsoft (MSFT) Q2 revenue up 20%, earnings beat estimates

Software giant Microsoft Corp. (NASDAQ: MSFT) on Tuesday reported higher revenues and earnings for the second quarter of 2022. The results also topped expectations. At $51.7 billion, second-quarter revenues were

January 25, 2022

NFLX Stock: What the slowdown in subscriber growth means for Netflix

When online platforms thrived on the unusually strong traffic growth during the shutdown, as home-bound people turned to video-streaming and gaming sites, there was speculation that the trend might reverse

January 24, 2022

Research Summary

McDonald’s Corp. (MCD) Q3 2021 research summary

McDonald’s is an American fast food company. Both earnings and revenues beat the Zacks

Trxade Health Inc. (NASDAQ: MEDS) Q4 2021 Research Summary

Trxade Health Inc. (NASDAQ: MEDS) is a healthcare service technology platform that mainly serves

Viewing Highlight